Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Myc inhibitor WBC100

An inhibitor of the proto-oncogene Myc (c-Myc), with potential antineoplastic activity. Upon administration, Myc inhibitor WBC100 targets and and inhibits Myc. This may inhibit proliferation in susceptible tumor cells. Myc, a proto-oncogene dysregulated in a variety of cancers, plays a role in the regulation of transcription and cell proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:c-Myc inhibitor WBC100
c-Myc targeting drug WBC100
Code name:WBC 100
WBC-100
WBC100
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search